NOWDx Test for the Diagnosis of Syphilis
Completed
Conditions studied: Syphilis Infection, Treponema Pallidum Infection
In brief
This study is designed to compare the performance of the NOWDx Syphilis Test to a currently marketed device. The intent is to show the rapid test device is comparable to the currently marketed device. The NOWDx Syphilis Test is intended for qualitatively detecting the presence or absence of human antibodies to syphilis in human whole blood to aid in the diagnosis of infection caused by Treponema pallidum.
Key facts
- Study ID
- NCT05063344
- Run by
- NOWDiagnostics, Inc.
- People needed
- 1535
- Starts
- 2021-10-04
- Expected to finish
- 2023-12-11
- Last updated by the study team
- 2024-02-29
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
Where it is running
- AMR Tempe — Tempe, Arizona, United States
- Matrix Clinical Research — Los Angeles, California, United States
- Segal Trials — North Miami, Florida, United States
- AMR Las Vegas — Las Vegas, Nevada, United States
- People Care Institute — West Orange, New Jersey, United States
- Multicare Rockwood — Cheney, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.